A world leader in developing vaccines and technologies to combat infectious diseases, the University of Saskatchewan’s (USask) Vaccine and Infectious Disease Organization-International Vaccine Centre (VIDO-InterVac) has partnered with Dalton Pharma Services (Dalton), as well as Biodextris, in the effort to develop a vaccine for COVID-19.
Just as redeploying a fleet of small British fishing boats helped during the Battle of Dunkirk, marshalling the research equipment and expertise of the many agtech labs around the world could help combat pandemics, say the authors of a just-published article in Nature Biotechnology.
A University of Saskatchewan (USask) research team has partnered with researchers across Canada to study how different types of affordable rental housing impact the lives of marginalized people and families.
In a significant step for Indigenous health research in Saskatchewan and nationally, a new University of Saskatchewan (USask)-led network dedicated to improving health and wellness in Indigenous communities will be moving into Station 20 West in a core neighborhood of Saskatoon’s west side.
University of Saskatchewan researcher Dr. Emilio Velez has received a prestigious postdoctoral fellowship through the Canadian Institutes of Health Research (CIHR).
Infectious disease experts from Dalhousie University and University of Manitoba (UM) are joining the leading-edge research team at the University of Saskatchewan’s (USask) Vaccine and Infectious Disease Organization-International Vaccine Centre (VIDO-InterVac) on one-year secondments to collaboratively advance research and development against COVID-19.
CFI awards $77.5M to help major USask science facilities address COVID-19 and other global challenges
Two of Canada’s top science facilities at the University of Saskatchewan (USask) have been awarded a total of more than $77.5 million—a third of the total $230 million announced today by Canada’s Minister of Innovation, Science and Industry Navdeep Bains for 14 research facilities across Canada.